A new EU research programme to develop ways of monitoring three main central nervous system conditions, epilepsy, multiple sclerosis (MS) and depressive disorder, using wearable devices and smartphones has been launched.
A new study just published indicates that children with Type 1 Diabetes are almost 3 times more likely to develop epilepsy as children without Type 1 Diabetes.
Despite recent advances in the understanding and treatment of epilepsy, up to 30% of people living with the condition do not respond to existing anti-epileptic drugs (AEDs) and continue to experience regular, debilitating and potentially life-threatening seizures.
Researchers at Case Western Reserve University in Ohio have discovered that, even in the absence of seizures, people with generalised epilepsy have differences in their heart activity compared to the average person.
The aim of this study was to explore the challenges that parents of children with epilepsy face when talking with their children about epilepsy and epilepsy-related issues.
Researchers in Australia have developed a new, minimally-invasive, brain-machine interface that could be beneficial in the treatment of epilepsy in future.
This 2015 Finnish study aimed to determine whether progress has been made in the prevention of epilepsy in Finland during the last 40 years.
Summary Findings from First National Audit of Neurology Services in Ireland.
On International Epilepsy Day today, the HSE's Chief Information Officer, Richard Corbridge will announce details of the HSE's new Epilepsy Lighthouse Project. The announcement will be made at Epilepsy Ireland's Epilepsy Research Explained event this evening at the RCSI in Dublin.
Epilepsy Ireland and Headway have joined forces today to launch an innovative new public awareness campaign called I See Beyond (#iseebeyond). The campaign focuses on raising awareness of hidden disabilities like epilepsy and acquired brain injury and the challenges these conditions can present in day to day life.